23andMe logo

23andMe Funding & Investors

Discover what 125+ personalized reports have to say about your ancestry, health, traits and more.

23andme.com

Total Amount Raised: $1,104,373,632

23andMe Funding Rounds

  • Post Ipo Equity

    $250,000,000

    Post Ipo Equity Investors

    Casdin Capital
    Fidelity Investments
    Foresite Capital
    Anne Wojcicki
    Altimeter Capital
    Richard Branson
  • Series F

    $82,500,000

    Series F Investors

    NewView Capital Management
    Sequoia Capital
    Pegasus Tech Ventures
  • Series F

    $250,000,000

    Series F Investors

    Sequoia Capital
    Fidelity Investments
    Euclidean Capital
    Altimeter Capital
    Wallenberg Foundations
    Casdin Capital
    G Squared
    Nimble Ventures
  • Post Ipo Equity

    $250,000,000

    Post Ipo Equity Investors

    Casdin Capital
    Fidelity Investments
    Foresite Capital
    Anne Wojcicki
    Altimeter Capital
    Richard Branson
  • Series E

    $115,000,000

    Series E Investors

    WuXi Healthcare Ventures
    Casdin Capital
    Xfund
    New Enterprise Associates (NEA)
    MPM Capital
    GV
    EquityZen
    Illumina Ventures
    Lauder Partners
  • Series F

    $82,500,000

    Series F Investors

    NewView Capital Management
    Sequoia Capital
    Pegasus Tech Ventures
  • Corporate Round

    $300,000,000

    Corporate Round Investors

    GSK
  • Series F

    $250,000,000

    Series F Investors

    Sequoia Capital
    Fidelity Investments
    Euclidean Capital
    Altimeter Capital
    Wallenberg Foundations
    Casdin Capital
    G Squared
    Nimble Ventures
  • Corporate Round

    $300,000,000

    Corporate Round Investors

    GSK
  • Grant

    $1,700,000

    Grant Investors

    National Institutes of Health (NIH)
  • Series C

    $9,000,000

    Series C Investors

    Johnson & Johnson Development
    MPM Capital
  • Series E

    $115,000,000

    Series E Investors

    WuXi Healthcare Ventures
    Casdin Capital
    Xfund
    New Enterprise Associates (NEA)
    MPM Capital
    GV
    EquityZen
    Illumina Ventures
    Lauder Partners
  • Series C

    $22,220,289

    Series C Investors

    Johnson & Johnson Development
    GV
    New Enterprise Associates (NEA)
  • Series C

    $22,220,289

    Series C Investors

    Johnson & Johnson Development
    GV
    New Enterprise Associates (NEA)
  • Series B

    $13,600,000

    Series B Investors

    Google
    Sergey Brin
    New Enterprise Associates (NEA)
  • Series B

    $13,600,000

    Series B Investors

    Google
    Sergey Brin
    New Enterprise Associates (NEA)
  • Series A

    $8,953,320

    Series A Investors

    Google
    New Enterprise Associates (NEA)
    Mohr Davidow Ventures
    Genentech
    Stephens Investment Management
    Wendi Deng Murdoch
  • Series A

    $8,953,320

    Series A Investors

    Google
    New Enterprise Associates (NEA)
    Mohr Davidow Ventures
    Genentech
    Stephens Investment Management
    Wendi Deng Murdoch
  • Grant

    $1,700,000

    Grant Investors

    National Institutes of Health (NIH)
  • Grant

    $1,400,000

    Grant Investors

    National Institutes of Health (NIH)
  • Series D

    $50,000,000

    Series D Investors

    GV
    Anne Wojcicki
    Sergey Brin
    New Enterprise Associates (NEA)
    MPM Capital
  • Grant

    $1,400,000

    Grant Investors

    National Institutes of Health (NIH)
  • Series D

    $50,000,000

    Series D Investors

    GV
    Anne Wojcicki
    Sergey Brin
    New Enterprise Associates (NEA)
    MPM Capital
Funding info provided by Diffbot.